Provided herein are a lappaconitine derivative of formula (I), and a preparation and application thereof.

##STR00001##

The invention of the instant application discloses spirocyclic guanidine compounds of general formula (I), shown below, and their use in methods of treating cancer

##STR00001##

Disclosed are an electroluminescent material and device. The compound is a compound formed by connecting an indole- and pyrrole-fused azamacrocycle to triazine or a similar structure thereof at a specific position and is used as the host material of the electroluminescent device. These novel compounds have significantly reduced evaporation temperature and better thermal stability, can effectively reduce energy consumption, which more facilitates the device manufacturing process, and in addition, can also effectively improve device efficiency and reduce device drive voltage, which can provide better device performance. Further disclosed are an electroluminescent device, a compound formulation, and a display assembly.

Disclosed are an electroluminescent material and device. The compound is a compound formed by connecting an indole- and pyrrole-fused azamacrocycle to triazine or a similar structure thereof at a specific position and is used as the host material of the electroluminescent device. These novel compounds have significantly reduced evaporation temperature and better thermal stability, can effectively reduce energy consumption, which more facilitates the device manufacturing process, and in addition, can also effectively improve device efficiency and reduce device drive voltage, which can provide better device performance. Further disclosed are an electroluminescent device, a compound formulation, and a display assembly.

Provided herein are a lappaconitine derivative of formula (I), and a preparation and application thereof. ##STR00001##

Provided herein are a lappaconitine derivative of formula (I), and a preparation and application thereof. ##STR00001##

The present disclosure relates to an organic electroluminescent compound, and an organic electroluminescent device comprising the same. By comprising the organic electroluminescent compound of the present disclosure, it is possible to provide an organic electroluminescent device having improved driving voltage, lifetime properties, and/or power efficiency.

The present disclosure relates to an organic electroluminescent compound, and an organic electroluminescent device comprising the same. By comprising the organic electroluminescent compound of the present disclosure, it is possible to provide an organic electroluminescent device having improved driving voltage, lifetime properties, and/or power efficiency.

The present invention relates to a process for the preparation of an isomer-enriched mixture of 3S- and 3R-caranone from 3-carane epoxide, a 3S-caranone obtained therefrom, a process for the production of 3S-caranlactam from 3-carene, a process for the production of 3R-caranlactam from 3-carene, a 3S-caranoxime, a 3S-caranlactam, a 3S-polycaranamide, a 3R-polycaranamide, a 3S/3R-co-polycaranamide, a 3S-caranlactam-laurolactam co-polycaranamide, a 3R-caranlactam-laurolactam co-polycaranamide, a 3S-caranlactam-3R-caranlactam-laurolactam co-polycaranamide, a 3S-caranlactam-caprolactam co-polycaranamide, a 3R-caranlactam-caprolactam co-polycaranamide, as well as a 3S/3R-caranlactam-caprolactam co-polycaranamide.

The present invention relates to a process for the preparation of an isomer-enriched mixture of 3S- and 3R-caranone from 3-carane epoxide, a 3S-caranone obtained therefrom, a process for the production of 3S-caranlactam from 3-carene, a process for the production of 3R-caranlactam from 3-carene, a 3S-caranoxime, a 3S-caranlactam, a 3S-polycaranamide, a 3R-polycaranamide, a 3S/3R-co-polycaranamide, a 3S-caranlactam-laurolactam co-polycaranamide, a 3R-caranlactam-laurolactam co-polycaranamide, a 3S-caranlactam-3R-caranlactam-laurolactam co-polycaranamide, a 3S-caranlactam-caprolactam co-polycaranamide, a 3R-caranlactam-caprolactam co-polycaranamide, as well as a 3S/3R-caranlactam-caprolactam co-polycaranamide.